Hypogonadism:
Indications for: Methyltestosterone
In males, primary and secondary hypogonadism, delayed puberty.
Adults and Children:
Usually 10–50mg daily. Delayed puberty: use low dose and limit duration to 4–6 months.
Methyltestosterone Contraindications:
Male breast or prostate carcinoma. Pregnancy (Cat.X).
Methyltestosterone Warnings/Precautions:
Discontinue if jaundice, abnormal liver function, hypercalcemia, or edema occurs. Cardiac, hepatic, or renal dysfunction. Monitor hepatic function, blood, and bone age. Elderly. Young children. Nursing mothers: not recommended.
Methyltestosterone Classification:
Androgen.
Methyltestosterone Interactions:
May potentiate oral anticoagulants, oxyphenbutazone. May alter insulin needs.
Adverse Reactions:
Peliosis hepatis, premature epiphyseal closure in adolescents, edema, hepatic carcinoma, prostatic hypertrophy or carcinoma, gynecomastia, priapism, oligospermia, nausea, jaundice, hirsutism, virilization, male pattern baldness, acne, polycythemia, headache, anxiety, depression, paresthesias, altered libido, fluid and electrolyte disturbances, suppression of clotting factors, increased serum cholesterol.
Note:
Formerly known under the brand names Android, Methitest, or Testred.
How Supplied:
Contact supplier
